Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.
The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR.
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo
Mechanical environment modulates biological properties of oligodendrocyte progenitor cells.
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Emotional Change-Associated T Cell Mobilization at the Early Stage of a Mouse Model of Multiple Sclerosis.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.
What Explains Gray Matter Atrophy in Long-standing Multiple Sclerosis?
Multiple sclerosis: risk factors, prodromes, and potential causal pathways.
Teva and Active Biotech remain committed to the development of NERVENTRA® (laquinimod) for multiple sclerosis following the negative opinion from the EMA's CHMP
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.
Natalizumab treatment during pregnancy - effects on the neonatal immune system.
New multiple sclerosis phenotypic classification.
Novel therapies for memory cells in autoimmune diseases.
Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.
Gait Mechanics are Different between Healthy Controls and Patients with Multiple Sclerosis.
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis.
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition.
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.
4th Biannual NeuroUnit Biomarkers for Inflammation and Neurodegeneration Symposium on Biomarkers in Neurodegenerative Disease
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis.

Pages